Researchers state that PSA (prostate-specific antigen) screening and DRE (digital rectal examination) are highly recommended for all prostate cancer patients with lower urinary tract symptoms (LUTSs), highlighting the crucial role of primary care physicians and general practitioners in the detection of prostate cancer in this population. This evidence concerns the gene PROS1 and prostate cancer.